抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Firivumab
All
TD-VK515026_1.jpg
- Catalog： TD-VK515026
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： CT-P22,CAS:1443004-15-6
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Firivumab
| Catalog No. | TD-VK515026 |
|---|---|
| Species reactivity | Influenza A virus |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG1, kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | HA/Hemagglutinin |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P03455 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | CT-P22,CAS:1443004-15-6 |
| Background | Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SDS-PAGE for Research Grade Firivumab. |